ALLO Stock Analysis: Buy, Sell, or Hold?
ALLO - Allogene Therapeutics, Inc. Common Stock
$1.88
-0.09 (-4.57%)
▼
5d:
+8.05%
30d:
-10.9%
90d:
-11.74%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
8d
Get Alerted When ALLO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ALLO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ALLO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ALLO is currently trading at $1.88, which is considered slightly low relative to its 30-day fair value range of $1.81 to $2.11.
Technical Outlook: Technically, ALLO is in a downtrend. Immediate support is located at $1.61, while resistance sits at $2.00. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: ALLO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+378.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALLO is in a downtrend. Immediate support is located at $1.61, while resistance sits at $2.00. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: ALLO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+378.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.81 -
$2.11
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 378.7% below Wall St target ($9.00)
Trading Range Analysis
30-Day Trading Range
$1.81 -
$2.11
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.61
Resistance Level
$2.00
Current Trend
Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.75
Wall Street Target
$9.00
(+378.7%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 03, 2026 1:49 AM ET
Data refreshes hourly during market hours. Next update: 2:49 AM
Data refreshes hourly during market hours. Next update: 2:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALLO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Annie Yoshiyama
SELL
9586 shares
2026-04-21
Benjamin Machinas Beneski
SELL
2867 shares
2026-03-31
Benjamin Machinas Beneski
SELL
4835 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
